Don’t see coverage of an asset you’re looking for? Let us know and we’ll add it to future snacks.

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our Multi-Factor Investor model based on the published strategy of ...

Stryker SYK has outperformed the market over the past 20 years by 2.57% on an annualized basis producing an average annual return of 10.84%. Currently, Stryker has a market capitalization of $145. ...

† School of Materials, The University of Manchester, Grosvenor Street, Manchester M1 7HS, United Kingdom ‡ Manchester Interdisciplinary Biocentre (MIB), The University of Manchester, 131 Princess ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts. Export articles to Mendeley Get article recommendations from ACS based on references in your ...

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our Multi-Factor Investor model based on the published strategy of ...

Stryker SYK recently received FDA clearance for its OptaBlate BVN Basivertebral Nerve Ablation System (OptaBlate BVN), a significant milestone in the treatment of chronic vertebrogenic lower back ...

Medical technology company Stryker (NYSE:SYK) announced better-than-expected revenue in Q1 CY2025, with sales up 11.9% year on year to $5.87 billion. Its non-GAAP profit of $2.84 per share was 4% ...